Abstract

Maximus is scheduled to release its fiscal third-quarter 2026 results on August 6, 2026, Pre-Market; this preview compiles the latest market forecasts, reviews last quarter’s performance, and analyzes what may matter most for revenue, margins, and earnings into the print.

Market Forecast

Market expectations point to a modest top-line expansion and a marked step-up in profitability for the coming quarter. The latest forecasts indicate revenue of 1.33 billion US dollars, implying 2.96% year-over-year growth, with estimated EBIT of 159.89 million US dollars (up 48.40% year-over-year) and adjusted EPS of 2.21 (up 55.83% year-over-year). Forecasts for gross profit margin and net profit margin were not disclosed and are therefore omitted.

Momentum is expected to be anchored by the company’s core operations in the United States, with stable execution on existing contracts providing the base and incremental tasking underpinning the outlook. Within the portfolio, the United States Health and Human Services unit appears positioned to benefit from steady casework and contact-center volumes; it delivered 415.75 million US dollars last quarter and, while segment-level year-over-year data was not disclosed, company-wide revenue growth of 2.96% year-over-year offers a reasonable directional benchmark.

Last Quarter Review

In the prior quarter, Maximus reported revenue of 1.31 billion US dollars, a gross profit margin of 26.21%, GAAP net profit attributable to shareholders of 98.06 million US dollars, a net profit margin of 7.51%, and adjusted EPS of 2.07; on a year-over-year basis, revenue declined 4.10% while adjusted EPS increased 2.99%. A notable highlight was earnings quality: adjusted EPS exceeded expectations by approximately 0.11, and EBIT topped forecasts by about 5.58 million US dollars, partially offsetting an 11.94 million US dollar revenue shortfall; sequentially, net profit rose by 4.39% on a quarter-over-quarter basis. From a business mix perspective, United States Federal Services contributed 753.14 million US dollars (57.67% of the quarter’s revenue), United States Health and Human Services contributed 415.75 million US dollars (31.84%), and Outside U.S. Services delivered 137.07 million US dollars (10.50%); segment-level year-over-year comparisons were not disclosed.

Current Quarter Outlook

United States Federal Services (Core revenue base)

The United States Federal Services segment remains the earnings anchor given its 57.67% contribution to last quarter’s revenue and its scale benefits to overhead absorption. With forecasts calling for 2.96% year-over-year growth in consolidated revenue and a sharp rise in EBIT and EPS, our base case assumes consistent delivery on established federal contracts, supported by incremental work orders that typically yield predictable revenue conversion. The margin trajectory will likely hinge on execution efficiency across high-volume programs, where stable staffing and optimized workflow can preserve the cost-to-serve profile even as activity levels fluctuate.

Operating leverage in this segment tends to materialize when task volumes are steady and fixed costs are largely covered early in the quarter, allowing additional revenue to convert to profit at higher incremental margins. That said, revenue mix within Federal Services can influence gross margin variability; business lines requiring dense labor support may cap near-term margin expansion, while fixed-price or high-value service components can lift contribution. Given last quarter’s gross profit margin of 26.21% at the consolidated level, investors will watch whether improved mix and operating discipline can hold or modestly improve margin into the upcoming print—even though explicit margin guidance for the quarter is not available. The significant step-up implied by EBIT and EPS forecasts suggests cost control and utilization efficiency are central to the implied earnings improvement.

United States Health and Human Services (Identified near-term upside)

United States Health and Human Services accounted for 31.84% of last quarter’s revenue, or 415.75 million US dollars, and is positioned as a near-term upside contributor due to its volume-sensitive service profile. This segment’s performance is typically linked to ongoing administrative and eligibility support functions, case processing, and citizen-engagement services; these activities can deliver incremental revenue gains with careful resource alignment and stable throughput. With company-wide revenue expected to grow 2.96% year-over-year for the current quarter and adjusted EPS forecast to rise 55.83% year-over-year, it is reasonable to anticipate that Health and Human Services can at least grow in line with the consolidated top line if service volumes and throughput remain on track.

The earnings translation for this segment depends on how efficiently staffing is matched to in-period demand, how well call and casework centers maintain service levels, and whether any contractual performance incentives are applicable. A favorable scenario would see steady to moderately higher volumes, allowing the business to leverage fixed infrastructure without incurring outsized overtime or attrition-related costs. While the company did not disclose segment-level year-over-year comparisons for the last quarter, the consolidated earnings trajectory—particularly the strong forecasts for EBIT and EPS—implies that either a modest lift in volumes or incremental efficiency gains could support this unit’s quarter-on-quarter profitability progression. Any signal that tasks are expanding or that service-level targets are being met with fewer hours per case would reinforce the positive earnings setup reflected in the forecasts.

Key stock drivers into the print (earnings quality, margins, and capital flexibility)

The first determinant for share performance around the release is earnings quality relative to the Street’s EPS estimate of 2.21. Last quarter, adjusted EPS topped consensus by around 0.11, despite a modest revenue miss, indicating healthy cost control and execution discipline; a repeat of that pattern, combined with even a slight revenue beat, would validate the forecasted 55.83% year-over-year EPS growth and likely be viewed favorably. Conversely, investors will scrutinize whether the earnings uplift is driven by sustainable operational levers or by transitory items; the presence of a 48.40% year-over-year EBIT uplift in forecasts points to genuine operating improvement as the primary driver.

The second key driver is margin trajectory relative to last quarter’s baselines. With a 26.21% gross profit margin and a 7.51% net profit margin most recently, even a modest continuation or improvement would support the sharp step-up in EPS that consensus expects. Absent explicit margin guidance, the mix between labor-intensive programs and higher-value tasking will shape gross margin print-through; any commentary indicating automation initiatives, workflow optimization, or improved contract economics would help explain how projected EBIT growth is achieved alongside restrained top-line growth. Investors should pay close attention to how consolidated margins reconcile with segment performance, especially given that Federal Services carries more than half of the revenue base.

The third stock driver is capital flexibility into the back half of the fiscal year. In late May 2026, the company executed a second amendment to its 2024 credit agreement, signaling ongoing access to committed liquidity and organizational attention to balance-sheet housekeeping. While the details were not emphasized in market commentary, such amendments typically refine covenant terms or extend borrowing flexibility, both supportive of working-capital needs tied to contract ramps and receivable timing. Healthy liquidity and disciplined capital management can reduce funding frictions, sustain program investments, and provide optionality for accretive internal initiatives; as a result, any additional color on funding costs or leverage should complement the profit outlook investors are already working with.

Finally, guidance calibration will matter for the stock reaction. Although the forecasts compiled here focus on the single-quarter print, the tone and direction of any qualitative outlook on revenue cadence and expense run-rates into the next quarter can influence valuation inputs. If management signals continued progress on profitability levers or indicates a stable demand environment across its U.S. operations, the market is likely to interpret the quarter’s earnings strength as repeatable rather than episodic. The combination of improved earnings conversion, stable top-line growth, and prudent balance-sheet management forms a coherent narrative aligning with the consensus uplift in EBIT and EPS.

Analyst Opinions

The collected views skew bullish, with a bullish-to-bearish ratio of 100% to 0% across the items identified in the review window. A noteworthy example is BTIG, which reaffirmed its Buy rating on July 10, 2026, and set a 100.00 US dollars price target. This stance aligns logically with the near-term earnings setup: forecasts call for adjusted EPS of 2.21, up 55.83% year-over-year, and EBIT of 159.89 million US dollars, up 48.40% year-over-year, even as revenue expansion is a modest 2.96% year-over-year. The asymmetric improvement in profitability relative to revenue implies better execution, cost control, and mix, each supporting the notion that earnings power is accelerating faster than the top line.

The bullish case emphasizes consistency in delivery and the potential for margins to either hold or modestly improve from last quarter’s baselines. Last quarter’s pattern—revenue of 1.31 billion US dollars with a 26.21% gross profit margin and a 7.51% net profit margin, plus an adjusted EPS beat—offers a tangible precedent that underpins confidence heading into the next print. Investors who subscribe to the bullish view see durability in this performance, particularly given how earnings outpaced revenue previously and how current forecasts envision a similar dynamic. Moreover, the recent amendment to the company’s credit agreement serves as an ancillary positive by supporting working-capital flexibility, which can reduce operational friction as contractual activity ebbs and flows over the quarter.

Parsing the majority opinion further, the positive stance is contingent upon the composition and quality of earnings, not just the headline growth rates. A clean beat that stems from operating leverage and process efficiencies would likely corroborate the 48.40% year-over-year EBIT growth forecast and validate the EPS trajectory. Commentary that clarifies resource utilization, contract mix, and workflow optimization will be viewed through the lens of repeatability. Should management communicate that cost improvements are structural—rather than one-time—analysts inclined to the bullish view would have grounds to maintain or even lift their constructive outlooks.

In addition, the balance of business contributions offers a favorable setup for earnings stability. With United States Federal Services providing 57.67% of last quarter’s revenue and United States Health and Human Services supplying 31.84%, the company enters the quarter with a diversified revenue base within its core geography, reducing single-program concentration risk in the near term. The bullish perspective is that steady execution across this base can sustain revenue even if discrete workstreams vary in intensity week to week, while process and technology refinements allow more of each revenue dollar to translate into EBIT and EPS—consistent with the forecasted skew toward profit growth.

The majority view is mindful that top-line growth expectations are measured at 2.96% year-over-year, yet is encouraged by the projected disproportionate gains in EBIT and EPS. This pattern supports a narrative of improving productivity and margin discipline that, if demonstrated again in the reported figures, can justify continued optimism. By anchoring on what is directly measurable—last quarter’s margin baselines, the recent earnings beat, and the current quarter’s EPS and EBIT forecasts—bullish analysts are framing a thesis that is testable and tied to the most impactful metrics around the release. Should results land in line with or above these expectations, the bias of institutional commentary is likely to remain positive in the near term.